| Remdesivir for the treatment of Covid-19 JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1826, 2020 | 5990 | 2020 |
| Remdesivir for the treatment of Covid-19—preliminary report JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ... New England Journal of Medicine 383 (19), 1813-1836, 2020 | 2535 | 2020 |
| Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance P Koehler, M Bassetti, A Chakrabarti, SCA Chen, AL Colombo, M Hoenigl, ... The Lancet Infectious Diseases 21 (6), e149-e162, 2021 | 737 | 2021 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 718 | 2021 |
| COVID‐19 associated pulmonary aspergillosis P Koehler, OA Cornely, BW Böttiger, F Dusse, DA Eichenauer, F Fuchs, ... Mycoses 63 (6), 528-534, 2020 | 587 | 2020 |
| COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment A Arastehfar, A Carvalho, FL van de Veerdonk, JD Jenks, P Koehler, ... Journal of Fungi 6 (2), 91, 2020 | 393 | 2020 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 297 | 2020 |
| Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19 P Bacher, E Rosati, D Esser, GR Martini, C Saggau, E Schiminsky, ... Immunity 53 (6), 1258-1271. e5, 2020 | 278 | 2020 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 255 | 2021 |
| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 250 | 2021 |
| Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis P Koehler, M Stecher, OA Cornely, D Koehler, MJGT Vehreschild, ... Clinical microbiology and infection 25 (10), 1200-1212, 2019 | 223 | 2019 |
| Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the … M Hoenigl, J Salmanton-García, TJ Walsh, M Nucci, CF Neoh, JD Jenks, ... The Lancet Infectious Diseases 21 (8), e246-e257, 2021 | 214 | 2021 |
| COVID-19–associated pulmonary aspergillosis, March–August 2020 J Salmanton-García, R Sprute, J Stemler, M Bartoletti, D Dupont, ... Emerging infectious diseases 27 (4), 1077, 2021 | 213 | 2021 |
| Diagnosing COVID-19-associated pulmonary aspergillosis PE Verweij, JP Gangneux, M Bassetti, RJM Brüggemann, OA Cornely, ... The Lancet Microbe 1 (2), e53-e55, 2020 | 191 | 2020 |
| Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of … J Prattes, J Wauters, DR Giacobbe, J Salmanton-García, J Maertens, ... Clinical Microbiology and Infection 28 (4), 580-587, 2022 | 168 | 2022 |
| COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry MM Rüthrich, C Giessen-Jung, S Borgmann, AY Classen, S Dolff, ... Annals of hematology 100, 383-393, 2021 | 164 | 2021 |
| Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis PE Verweij, RJM Brüggemann, E Azoulay, M Bassetti, S Blot, JB Buil, ... Intensive care medicine 47 (8), 819-834, 2021 | 127 | 2021 |
| Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19 SJ Theobald, A Simonis, T Georgomanolis, C Kreer, M Zehner, HS Eisfeld, ... EMBO molecular medicine 13 (8), e14150, 2021 | 115 | 2021 |
| Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope® D Seidel, A Meißner, M Lackner, E Piepenbrock, J Salmanton-García, ... Critical reviews in microbiology 45 (1), 1-21, 2019 | 113 | 2019 |
| Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study P Koehler, A Hamprecht, O Bader, I Bekeredjian-Ding, D Buchheidt, ... International journal of antimicrobial agents 49 (2), 218-223, 2017 | 91 | 2017 |
